471 related articles for article (PubMed ID: 23136553)
21. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling.
Sanchez-Lopez E; Flashner-Abramson E; Shalapour S; Zhong Z; Taniguchi K; Levitzki A; Karin M
Oncogene; 2016 May; 35(20):2634-44. PubMed ID: 26364612
[TBL] [Abstract][Full Text] [Related]
22. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 signalling in health and disease.
Rose-John S
F1000Res; 2020; 9():. PubMed ID: 32864098
[TBL] [Abstract][Full Text] [Related]
24. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L
Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257
[TBL] [Abstract][Full Text] [Related]
25. Targeting Interleukin-6 Signaling in Clinic.
Kang S; Tanaka T; Narazaki M; Kishimoto T
Immunity; 2019 Apr; 50(4):1007-1023. PubMed ID: 30995492
[TBL] [Abstract][Full Text] [Related]
26. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
[TBL] [Abstract][Full Text] [Related]
28. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
[TBL] [Abstract][Full Text] [Related]
29. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
[TBL] [Abstract][Full Text] [Related]
30. [Immune Regulation by TNF Receptor-associated Factor 5].
So T
Yakugaku Zasshi; 2024; 144(5):489-496. PubMed ID: 38692922
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis.
Nowell MA; Williams AS; Carty SA; Scheller J; Hayes AJ; Jones GW; Richards PJ; Slinn S; Ernst M; Jenkins BJ; Topley N; Rose-John S; Jones SA
J Immunol; 2009 Jan; 182(1):613-22. PubMed ID: 19109195
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas.
Osuka K; Watanabe Y; Usuda N; Aoyama M; Iwami K; Takeuchi M; Watabe T; Takayasu M
J Neurotrauma; 2017 Jun; 34(11):1996-2000. PubMed ID: 28027695
[TBL] [Abstract][Full Text] [Related]
34. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
35. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
36. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
38. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps.
Peters AT; Kato A; Zhang N; Conley DB; Suh L; Tancowny B; Carter D; Carr T; Radtke M; Hulse KE; Seshadri S; Chandra R; Grammer LC; Harris KE; Kern R; Schleimer RP
J Allergy Clin Immunol; 2010 Feb; 125(2):397-403.e10. PubMed ID: 20159251
[TBL] [Abstract][Full Text] [Related]
39. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer.
Taher MY; Davies DM; Maher J
Biochem Soc Trans; 2018 Dec; 46(6):1449-1462. PubMed ID: 30467123
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer cell-derived interleukin-6 enhances the phagocytic capacity and migration of THP-1 cells.
Yeh KY; Wu TH; Wu TL
Cytokine; 2016 Mar; 79():82-9. PubMed ID: 26775116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
